Regulation of caspases in the nervous system: Implications for functions in health and disease

Progress in Molecular Biology and Translational Science

Volumn 99, Issue C, 2011, Pages 265-305

  Troy, Carol M ^a   Akpan, Nsikan ^a   Jean, Ying Y ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

Alzheimer's Disease; Caspase; Cerebral ischemia; Development; Inhibitor of apoptosis protein; Stroke; Synaptic plasticity

Indexed keywords

EID: 78751626397     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385504-6.00007-5     Document Type: Chapter

References (243)

1. M. Miura, H. Zhu, R. Rotello, E.A. Hartwieg, and J. Yuan Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3 Cell 75 1993 653 660
2. N.A. Thornberry, H.G. Bull, J.R. Calaycay, K.T. Chapman, A.D. Howard, and M.J. Kostura A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes Nature 356 1992 768 774
3. J. Yuan, S. Shaham, S. Ledoux, H.M. Ellis, and H.R. Horvitz The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme Cell 75 1993 641 652
4. L. Eckhart, J. Ban, H. Fischer, and E. Tschachler Caspase-14: analysis of gene structure and mRNA expression during keratinocyte differentiation Biochem Biophys Res Commun 277 2000 655 659
5. H. Fischer, U. Koenig, L. Eckhart, and E. Tschachler Human caspase 12 has acquired deleterious mutations Biochem Biophys Res Commun 293 2002 722 726
6. S. Roy, J.R. Sharom, C. Houde, T.P. Loisel, J.P. Vaillancourt, and W. Shao Confinement of caspase-12 proteolytic activity to autoprocessing Proc Natl Acad Sci USA 105 2008 4133 4138
7. E.M. Kim, E.J. Shin, J.H. Choi, H.J. Son, I.S. Park, and T.H. Joh Matrix metalloproteinase-3 is increased and participates in neuronal apoptotic signaling downstream of caspase-12 during endoplasmic reticulum stress J Biol Chem 285 2010 16444 16452
8. K.M. Boatright, and G.S. Salvesen Caspase activation Biochem Soc Symp 70 2003 233 242
9. C. Pop, and G.S. Salvesen Human caspases: activation, specificity, and regulation J Biol Chem 284 2009 21777 21781
10. K.M. Boatright, M. Renatus, F.L. Scott, S. Sperandio, H. Shin, and I.M. Pedersen A unified model for apical caspase activation Mol Cell 11 2003 529 541
11. J.M. Adams, and S. Cory The Bcl-2 apoptotic switch in cancer development and therapy Oncogene 26 2007 1324 1337
12. B.C. Baliga, S.H. Read, and S. Kumar The biochemical mechanism of caspase-2 activation Cell Death Differ 11 2004 1234 1241
13. H.R. Stennicke, Q.L. Deveraux, E.W. Humke, J.C. Reed, V.M. Dixit, and G.S. Salvesen Caspase-9 can be activated without proteolytic processing J Biol Chem 274 1999 8359 8362
14. A. Oberst, C. Pop, A.G. Tremblay, V. Blais, J.B. Denault, and G.S. Salvesen Inducible dimerization and inducible cleavage reveal a requirement for both processes in caspase-8 activation J Biol Chem 285 2010 16632 16642
15. S.J. Riedl, and G.S. Salvesen The apoptosome: signalling platform of cell death Nat Rev 8 2007 405 413
16. J.B. Denault, B.P. Eckelman, H. Shin, C. Pop, and G.S. Salvesen Caspase 3 attenuates XIAP (X-linked inhibitor of apoptosis protein)-mediated inhibition of caspase 9 Biochem J 405 2007 11 19
17. T.B. Kang, G.S. Oh, E. Scandella, B. Bolinger, B. Ludewig, and A. Kovalenko Mutation of a self-processing site in caspase-8 compromises its apoptotic but not its nonapoptotic functions in bacterial artificial chromosome-transgenic mice J Immunol 181 2008 2522 2532
18. L. Wang, F. Du, and X. Wang TNF-alpha induces two distinct caspase-8 activation pathways Cell 133 2008 693 703
19. S.H. Jia, J. Parodo, A. Kapus, O.D. Rotstein, and J.C. Marshall Dynamic regulation of neutrophil survival through tyrosine phosphorylation or dephosphorylation of caspase-8 J Biol Chem 283 2008 5402 5413
20. A. Tinel, and J. Tschopp The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress Science 304 2004 843 846
21. C.M. Troy, and E.M. Ribe Caspase-2: vestigial remnant or master regulator? Sci Signal 1 2008 pe42
22. C. Manzl, G. Krumschnabel, F. Bock, B. Sohm, V. Labi, and F. Baumgartner Caspase-2 activation in the absence of PIDDosome formation J Cell Biol 185 2009 291 303
23. I.R. Kim, K. Murakami, N.J. Chen, S.D. Saibil, E. Matysiak-Zablocki, and A.R. Elford DNA damage- and stress-induced apoptosis occurs independently of PIDD Apoptosis 14 2009 1039 1049
24. C. Berube, L.M. Boucher, W. Ma, A. Wakeham, L. Salmena, and R. Hakem Apoptosis caused by p53-induced protein with death domain (PIDD) depends on the death adapter protein RAIDD Proc Natl Acad Sci USA 102 2005 14314 14320
25. A. Tinel, S. Janssens, S. Lippens, S. Cuenin, E. Logette, and B. Jaccard Autoproteolysis of PIDD marks the bifurcation between pro-death caspase-2 and pro-survival NF-kappaB pathway EMBO J 26 2007 197 208
26. S. Cuenin, A. Tinel, S. Janssens, and J. Tschopp p53-induced protein with a death domain (PIDD) isoforms differentially activate nuclear factor-kappaB and caspase-2 in response to genotoxic stress Oncogene 27 2008 387 396
27. L.K. Nutt, S.S. Margolis, M. Jensen, C.E. Herman, W.G. Dunphy, and J.C. Rathmell Metabolic regulation of oocyte cell death through the CaMKII-mediated phosphorylation of caspase-2 Cell 123 2005 89 103
28. S. Shin, Y. Lee, W. Kim, H. Ko, H. Choi, and K. Kim Caspase-2 primes cancer cells for TRAIL-mediated apoptosis by processing procaspase-8 EMBO J 24 2005 3532 3542
29. L.K. Nutt, M.R. Buchakjian, E. Gan, R. Darbandi, S.Y. Yoon, and J.Q. Wu Metabolic control of oocyte apoptosis mediated by 14-3-3zeta-regulated dephosphorylation of caspase-2 Dev Cell 16 2009 856 866
30. G. Trendelenburg Acute neurodegeneration and the inflammasome: central processor for danger signals and the inflammatory response? J Cereb Blood Flow Metab 28 2008 867 881
31. F. Martinon, K. Burns, and J. Tschopp The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta Mol Cell 10 2002 417 426
32. L. Agostini, F. Martinon, K. Burns, M.F. McDermott, P.N. Hawkins, and J. Tschopp NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder Immunity 20 2004 319 325
33. V. Petrilli, S. Papin, and J. Tschopp The inflammasome Curr Biol 15 2005 R581
34. J. Tschopp, and K. Schroder NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nat Rev Immunol 10 2010 210 215
35. F. Martinon, and J. Tschopp Inflammatory caspases and inflammasomes: master switches of inflammation Cell Death Differ 14 2007 10 22
36. V. Petrilli, C. Dostert, D.A. Muruve, and J. Tschopp The inflammasome: a danger sensing complex triggering innate immunity Curr Opin Immunol 19 2007 615 622
37. S.M. Srinivasula, and J.D. Ashwell IAPs: what's in a name? Mol Cell 30 2008 123 135
38. B.P. Eckelman, G.S. Salvesen, and F.L. Scott Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family EMBO Rep 7 2006 988 994
39. B.P. Eckelman, and G.S. Salvesen The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases J Biol Chem 281 2006 3254 3260
40. M. Irmler, M. Thome, M. Hahne, P. Schneider, K. Hofmann, and V. Steiner Inhibition of death receptor signals by cellular FLIP Nature 388 1997 190 195
41. C. Du, M. Fang, Y. Li, L. Li, and X. Wang Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition Cell 102 2000 33 42
42. A.M. Verhagen, P.G. Ekert, M. Pakusch, J. Silke, L.M. Connolly, and G.E. Reid Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins Cell 102 2000 43 53
43. R. Hegde, S.M. Srinivasula, Z. Zhang, R. Wassell, R. Mukattash, and L. Cilenti Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction J Biol Chem 277 2002 432 438
44. P. Liston, W.G. Fong, N.L. Kelly, S. Toji, T. Miyazaki, and D. Conte Identification of XAF1 as an antagonist of XIAP anti-Caspase activity Nat Cell Biol 3 2001 128 133
45. V. Arora, H.H. Cheung, S. Plenchette, O.C. Micali, P. Liston, and R.G. Korneluk Degradation of survivin by the X-linked inhibitor of apoptosis (XIAP)-XAF1 complex J Biol Chem 282 2007 26202 26209
46. D.W. Chang, Z. Xing, V.L. Capacio, M.E. Peter, and X. Yang Interdimer processing mechanism of procaspase-8 activation EMBO J 22 2003 4132 4142
47. C. Pop, P. Fitzgerald, D.R. Green, and G.S. Salvesen Role of proteolysis in caspase-8 activation and stabilization Biochemistry 46 2007 4398 4407
48. N.A. Thornberry, T.A. Rano, E.P. Peterson, D.M. Rasper, T. Timkey, and M. Garcia-Calvo A combinatorial approach defines specificities of members of the caspase family and granzyme B Functional relationships established for key mediators of apoptosis J Biol Chem 272 1997 17907 17911
49. R.V. Talanian, C. Quinlan, S. Trautz, M.C. Hackett, J.A. Mankovich, and D. Banach Substrate specificities of caspase family proteases J Biol Chem 272 1997 9677 9682
50. G.P. McStay, G.S. Salvesen, and D.R. Green Overlapping cleavage motif selectivity of caspases: implications for analysis of apoptotic pathways Cell Death Differ 15 2008 322 331
51. S. Tu, G.P. McStay, L.M. Boucher, T. Mak, H.M. Beere, and D.R. Green In situ trapping of activated initiator caspases reveals a role for caspase-2 in heat shock-induced apoptosis Nat Cell Biol 8 2006 72 77
52. L. Bouchier-Hayes, A. Oberst, G.P. McStay, S. Connell, S.W. Tait, and C.P. Dillon Characterization of cytoplasmic caspase-2 activation by induced proximity Mol Cell 35 2009 830 840
53. T. Kitevska, D.M. Spencer, and C.J. Hawkins Caspase-2: controversial killer or checkpoint controller? Apoptosis 14 2009 829 848
54. K. Kuida, T.F. Haydar, C.Y. Kuan, Y. Gu, C. Taya, and H. Karasuyama Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9 Cell 94 1998 325 337
55. F. Cecconi, G. Alvarez-Bolado, B.I. Meyer, K.A. Roth, and P. Gruss Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development Cell 94 1998 727 737
56. R. Hakem, A. Hakem, G.S. Duncan, J.T. Henderson, M. Woo, and M.S. Soengas Differential requirement for caspase 9 in apoptotic pathways in vivo Cell 94 1998 339 352
57. H. Yoshida, Y.Y. Kong, R. Yoshida, A.J. Elia, A. Hakem, and R. Hakem Apaf1 is required for mitochondrial pathways of apoptosis and brain development Cell 94 1998 739 750
58. K. Kuida, T.S. Zheng, S. Na, C. Kuan, D. Yang, and H. Karasuyama Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice Nature 384 1996 368 372
59. S. Namura, J. Zhu, K. Fink, M. Endres, A. Srinivasan, and K.J. Tomaselli Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia J Neurosci 18 1998 3659 3668
60. K. Kuida, J.A. Lippke, G. Ku, M.W. Harding, D.J. Livingston, and M.S. Su Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme Science 267 1995 2000 2003
61. L. Bergeron, G.I. Perez, G. Macdonald, L. Shi, Y. Sun, and A. Jurisicova Defects in regulation of apoptosis in caspase-2-deficient mice Genes Dev 12 1998 1304 1314
62. S. Wang, M. Miura, Y.K. Jung, H. Zhu, E. Li, and J. Yuan Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE Cell 92 1998 501 509
63. T.S. Zheng, S. Hunot, K. Kuida, T. Momoi, A. Srinivasan, and D.W. Nicholson Deficiency in caspase-9 or caspase-3 induces compensatory caspase activation Nat Med 6 2000 1241 1247
64. C.M. Troy, S.A. Rabacchi, J.B. Hohl, J.M. Angelastro, L.A. Greene, and M.L. Shelanski Death in the balance: alternative participation of the caspase-2 and -9 pathways in neuronal death induced by nerve growth factor deprivation J Neurosci 21 2001 5007 5016
65. M. D'Amelio, V. Cavallucci, and F. Cecconi Neuronal caspase-3 signaling: not only cell death Cell Death Differ 17 2010 1104 1114
66. P. Fernando, S. Brunette, and L.A. Megeney Neural stem cell differentiation is dependent upon endogenous caspase 3 activity FASEB J 19 2005 1671 1673
67. M.M. Aranha, S. Sola, W.C. Low, C.J. Steer, and C.M. Rodrigues Caspases and p53 modulate FOXO3A/Id1 signaling during mouse neural stem cell differentiation J Cell Biochem 107 2009 748 758
68. D.W. Williams, S. Kondo, A. Krzyzanowska, Y. Hiromi, and J.W. Truman Local caspase activity directs engulfment of dendrites during pruning Nat Neurosci 9 2006 1234 1236
69. A. Nikolaev, T. McLaughlin, D.D. O'Leary, and M. Tessier-Lavigne APP binds DR6 to trigger axon pruning and neuron death via distinct caspases Nature 457 2009 981 989
70. G.R. Huesmann, and D.F. Clayton Dynamic role of postsynaptic caspase-3 and BIRC4 in zebra finch song-response habituation Neuron 52 2006 1061 1072
71. N.V. Gulyaeva, I.E. Kudryashov, and I.V. Kudryashova Caspase activity is essential for long-term potentiation J Neurosci Res 73 2003 853 864
72. M.Y. Stepanichev, I.V. Kudryashova, A.A. Yakovlev, M.V. Onufriev, L.G. Khaspekov, and A.A. Lyzhin Central administration of a caspase inhibitor impairs shuttle-box performance in rats Neuroscience 136 2005 579 591
73. Z. Li, J. Jo, J.M. Jia, S.C. Lo, D.J. Whitcomb, and S. Jiao Caspase-3 activation via mitochondria is required for long-term depression and AMPA receptor internalization Cell 141 2010 859 871
74. Y. Gu, J.W. Nieves, Y. Stern, J.A. Luchsinger, and N. Scarmeas Food combination and Alzheimer disease risk: a protective diet Arch Neurol 67 2010 699 706
75. M.A. Pappolla, Y.J. Chyan, B. Poeggeler, B. Frangione, G. Wilson, and J. Ghiso An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease J Neural Transm 107 2000 203 231
76. K. Blennow, M.J. de Leon, and H. Zetterberg Alzheimer's disease Lancet 368 2006 387 403
77. A. Alzheimer, R.A. Stelzmann, H.N. Schnitzlein, and F.R. Murtagh An English translation of Alzheimer's 1907 paper, "Uber eine eigenartige Erkankung der Hirnrinde" Clin Anat 8 1995 429 431
78. G.W. Small, P.V. Rabins, P.P. Barry, N.S. Buckholtz, S.T. DeKosky, and S.H. Ferris Diagnosis and treatment of Alzheimer disease and related disorders consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society JAMA 278 1997 1363 1371
79. R.D. Terry, A. Peck, R. DeTeresa, R. Schechter, and D.S. Horoupian Some morphometric aspects of the brain in senile dementia of the Alzheimer type Ann Neurol 10 1981 184 192
80. S.A. Scott, S.T. DeKosky, D.L. Sparks, C.A. Knox, and S.W. Scheff Amygdala cell loss and atrophy in Alzheimer's disease Ann Neurol 32 1992 555 563
81. Z.S. Khachaturian Toward a comprehensive theory of Alzheimer's diseasechallenges, caveats, and parameters Ann NY Acad Sci 924 2000 184 193
82. Z.S. Khachaturian Neurobiology of aging: Alzheimer's clinical review series. Bridging bench to bedside: clinical problems in search of basic solution Neurobiol Aging 21 2000 843
83. S.E. Arnold, B.T. Hyman, J. Flory, A.R. Damasio, and G.W. Van Hoesen The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease Cereb Cortex 1 1991 103 116
84. H. Braak, and E. Braak Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections Brain Pathol 1 1991 213 216
85. H. Braak, and E. Braak Morphological changes in the human cerebral cortex in dementia J Hirnforsch 32 1991 277 282
86. P.V. Arriagada, K. Marzloff, and B.T. Hyman Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease Neurology 42 1992 1681 1688
87. P.V. Arriagada, J.H. Growdon, E.T. Hedley-Whyte, and B.T. Hyman Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease Neurology 42 1992 631 639
88. A. Goate, M.C. Chartier-Harlin, M. Mullan, J. Brown, F. Crawford, and L. Fidani Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease Nature 349 1991 704 706
89. R. Sherrington, E.I. Rogaev, Y. Liang, E.A. Rogaeva, G. Levesque, and M. Ikeda Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease Nature 375 1995 754 760
90. E. Levy-Lahad, E.M. Wijsman, E. Nemens, L. Anderson, K.A. Goddard, and J.L. Weber A familial Alzheimer's disease locus on chromosome 1 Science 269 1995 970 973
91. A. Kowalska, D. Pruchnik-Wolinska, J. Florczak, R. Modestowicz, J. Szczech, and W. Kozubski Genetic study of familial cases of Alzheimer's disease Acta Biochim Pol 51 2004 245 252
92. A. Kowalska, D. Pruchnik-Wolinska, J. Florczak, J. Szczech, W. Kozubski, and G. Rossa Presenilin 1 mutations in Polish families with early-onset Alzheimer's disease Folia Neuropathol 42 2004 9 14
93. D. Games, D. Adams, R. Alessandrini, R. Barbour, P. Berthelette, and C. Blackwell Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein Nature 373 1995 523 527
94. K.K. Hsiao, D.R. Borchelt, K. Olson, R. Johannsdottir, C. Kitt, and W. Yunis Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins Neuron 15 1995 1203 1218
95. K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, and S. Younkin Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice Science 274 1996 99 102
96. K. Johnson-Wood, M. Lee, R. Motter, K. Hu, G. Gordon, and R. Barbour Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease Proc Natl Acad Sci USA 94 1997 1550 1555
97. C. Sturchler-Pierrat, D. Abramowski, M. Duke, K.H. Wiederhold, C. Mistl, and S. Rothacher Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology Proc Natl Acad Sci USA 94 1997 13287 13292
98. K. Terai, A. Iwai, S. Kawabata, Y. Tasaki, T. Watanabe, and K. Miyata beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease Neuroscience 104 2001 299 310
99. M.J. Callahan, W.J. Lipinski, F. Bian, R.A. Durham, A. Pack, and L.C. Walker Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice Am J Pathol 158 2001 1173 1177
100. J. Gotz, A. Probst, M.G. Spillantini, T. Schafer, R. Jakes, and K. Burki Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform EMBO J 14 1995 1304 1313
101. J. Gotz, F. Chen, R. Barmettler, and R.M. Nitsch Tau filament formation in transgenic mice expressing P301L tau J Biol Chem 276 2001 529 534
102. J.P. Brion, G. Tremp, and J.N. Octave Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease Am J Pathol 154 1999 255 270
103. K. Spittaels, C. Van den Haute, J. Van Dorpe, K. Bruynseels, K. Vandezande, and I. Laenen Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein Am J Pathol 155 1999 2153 2165
104. A. Probst, J. Gotz, K.H. Wiederhold, M. Tolnay, C. Mistl, and A.L. Jaton Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein Acta Neuropathol 99 2000 469 481
105. J. Lewis, E. McGowan, J. Rockwood, H. Melrose, P. Nacharaju, and M. Van Slegtenhorst Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein Nat Genet 25 2000 402 405
106. K. Tanemura, T. Akagi, M. Murayama, N. Kikuchi, O. Murayama, and T. Hashikawa Formation of filamentous tau aggregations in transgenic mice expressing V337M human tau Neurobiol Dis 8 2001 1036 1045
107. K. Tanemura, M. Murayama, T. Akagi, T. Hashikawa, T. Tominaga, and M. Ichikawa Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau J Neurosci 22 2002 133 141
108. F. Lim, F. Hernandez, J.J. Lucas, P. Gomez-Ramos, M.A. Moran, and J. Avila FTDP-17 mutations in tau transgenic mice provoke lysosomal abnormalities and Tau filaments in forebrain Mol Cell Neurosci 18 2001 702 714
109. Y. Tatebayashi, T. Miyasaka, D.H. Chui, T. Akagi, K. Mishima, and K. Iwasaki Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau Proc Natl Acad Sci USA 99 2002 13896 13901
110. J. Gotz, F. Chen, J. van Dorpe, and R.M. Nitsch Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils Science 293 2001 1491 1495
111. M. Meyer-Luehmann, T.L. Spires-Jones, C. Prada, M. Garcia-Alloza, A. de Calignon, and A. Rozkalne Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease Nature 451 2008 720 724
112. C. De Jonghe, C. Esselens, S. Kumar-Singh, K. Craessaerts, S. Serneels, and F. Checler Pathogenic APP mutations near the gamma-secretase cleavage site differentially affect Abeta secretion and APP C-terminal fragment stability Hum Mol Genet 10 2001 1665 1671
113. T.E. Golde, and C. Janus Homing in on intracellular Abeta? Neuron 45 2005 639 642
114. T.E. Golde The Abeta hypothesis: leading us to rationally-designed therapeutic strategies for the treatment or prevention of Alzheimer disease Brain Pathol 15 2005 84 87
115. A. Kowalska Genetic aspects of amyloid beta-protein fibrillogenesis in Alzheimer's disease Folia Neuropathol 42 2004 235 237
116. J. Theuns, E. Marjaux, M. Vandenbulcke, K. Van Laere, S. Kumar-Singh, and G. Bormans Alzheimer dementia caused by a novel mutation located in the APP C-terminal intracytosolic fragment Hum Mutat 27 2006 888 896
117. J. Theuns, N. Brouwers, S. Engelborghs, K. Sleegers, V. Bogaerts, and E. Corsmit Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease Am J Hum Genet 78 2006 936 946
118. E.S. Walker, M. Martinez, A.L. Brunkan, and A. Goate Presenilin 2 familial Alzheimer's disease mutations result in partial loss of function and dramatic changes in Abeta 42/40 ratios J Neurochem 92 2005 294 301
119. C. Duyckaerts, M.C. Potier, and B. Delatour Alzheimer disease models and human neuropathology: similarities and differences Acta Neuropathol 115 2008 5 38
120. R.M. Koffie, M. Meyer-Luehmann, T. Hashimoto, K.W. Adams, M.L. Mielke, and M. Garcia-Alloza Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques Proc Natl Acad Sci USA 106 2009 4012 4017
121. M.P. Lambert, A.K. Barlow, B.A. Chromy, C. Edwards, R. Freed, and M. Liosatos Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins Proc Natl Acad Sci USA 95 1998 6448 6453
122. H.W. Wang, J.F. Pasternak, H. Kuo, H. Ristic, M.P. Lambert, and B. Chromy Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus Brain Res 924 2002 133 140
123. D.M. Walsh, B.P. Tseng, R.E. Rydel, M.B. Podlisny, and D.J. Selkoe The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain Biochemistry 39 2000 10831 10839
124. D.M. Walsh, I. Klyubin, J.V. Fadeeva, M.J. Rowan, and D.J. Selkoe Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition Biochem Soc Trans 30 2002 552 557
125. S. Barghorn, V. Nimmrich, A. Striebinger, C. Krantz, P. Keller, and B. Janson Globular amyloid beta-peptide oligomera homogenous and stable neuropathological protein in Alzheimer's disease J Neurochem 95 2005 834 847
126. S. Lesne, M.T. Koh, L. Kotilinek, R. Kayed, C.G. Glabe, and A. Yang A specific amyloid-beta protein assembly in the brain impairs memory Nature 440 2006 352 357
127. V. Nimmrich, C. Grimm, A. Draguhn, S. Barghorn, A. Lehmann, and H. Schoemaker Amyloid beta oligomers (A beta(1-42) globulomer) suppress spontaneous synaptic activity by inhibition of P/Q-type calcium currents J Neurosci 28 2008 788 797
128. C.W. Cotman, and A.J. Anderson A potential role for apoptosis in neurodegeneration and Alzheimer's disease Mol Neurobiol 10 1995 19 45
129. F.G. Gervais, D. Xu, G.S. Robertson, J.P. Vaillancourt, Y. Zhu, and J. Huang Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation Cell 97 1999 395 406
130. P.N. Pompl, S. Yemul, Z. Xiang, L. Ho, V. Haroutunian, and D. Purohit Caspase gene expression in the brain as a function of the clinical progression of Alzheimer disease Arch Neurol 60 2003 369 376
131. A. LeBlanc, H. Liu, C. Goodyer, C. Bergeron, and J. Hammond Caspase-6 role in apoptosis of human neurons, amyloidogenesis, and Alzheimer's disease J Biol Chem 274 1999 23426 23436
132. C. Stadelmann, T.L. Deckwerth, A. Srinivasan, C. Bancher, W. Bruck, and K. Jellinger Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death Am J Pathol 155 1999 1459 1466
133. T. Matsui, K. Ramasamy, M. Ingelsson, H. Fukumoto, C. Conrad, and M.P. Frosch Coordinated expression of caspase 8, 3 and 7 mRNA in temporal cortex of Alzheimer disease: relationship to formic acid extractable abeta42 levels J Neuropathol Exp Neurol 65 2006 508 515
134. T.T. Rohn, E. Head, W.H. Nesse, C.W. Cotman, and D.H. Cribbs Activation of caspase-8 in the Alzheimer's disease brain Neurobiol Dis 8 2001 1006 1016
135. D.C. Lu, S. Rabizadeh, S. Chandra, R.F. Shayya, L.M. Ellerby, and X. Ye A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor Nat Med 6 2000 397 404
136. L. Pellegrini, B.J. Passer, M. Tabaton, J.K. Ganjei, and L. D'Adamio Alternative, non-secretase processing of Alzheimer's beta-amyloid precursor protein during apoptosis by caspase-6 and -8 J Biol Chem 274 1999 21011 21016
137. D.L. McPhie, T. Golde, C.B. Eckman, D. Yager, J.B. Brant, and R.L. Neve beta-Secretase cleavage of the amyloid precursor protein mediates neuronal apoptosis caused by familial Alzheimer's disease mutations Brain Res Mol Brain Res 97 2001 103 113
138. E.H. Koo The beta-amyloid precursor protein (APP) and Alzheimer's disease: does the tail wag the dog? Traffic 3 2002 763 770
139. H. Zheng, and E.H. Koo The amyloid precursor protein: beyond amyloid Mol Neurodegener 1 2006 5
140. D.C. Lu, S. Soriano, D.E. Bredesen, and E.H. Koo Caspase cleavage of the amyloid precursor protein modulates amyloid beta-protein toxicity J Neurochem 87 2003 733 741
141. V. Galvan, J. Zhang, O.F. Gorostiza, S. Banwait, W. Huang, and M. Ataie Long-term prevention of Alzheimer's disease-like behavioral deficits in PDAPP mice carrying a mutation in Asp664 Behav Brain Res 191 2008 246 255
142. J.A. Harris, N. Devidze, B. Halabisky, I. Lo, M.T. Thwin, and G.Q. Yu Many neuronal and behavioral impairments in transgenic mouse models of Alzheimer's disease are independent of caspase cleavage of the amyloid precursor protein J Neurosci 30 2010 372 381
143. T.C. Gamblin, F. Chen, A. Zambrano, A. Abraha, S. Lagalwar, and A.L. Guillozet Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease Proc Natl Acad Sci USA 100 2003 10032 10037
144. R.A. Rissman, W.W. Poon, M. Blurton-Jones, S. Oddo, R. Torp, and M.P. Vitek Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology J Clin Invest 114 2004 121 130
145. H. Guo, S. Albrecht, M. Bourdeau, T. Petzke, C. Bergeron, and A.C. LeBlanc Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease Am J Pathol 165 2004 523 531
146. S. Albrecht, N. Bogdanovic, B. Ghetti, B. Winblad, and A.C. LeBlanc Caspase-6 activation in familial alzheimer disease brains carrying amyloid precursor protein or presenilin i or presenilin II mutations J Neuropathol Exp Neurol 68 2009 1282 1293
147. A. de Calignon, L.M. Fox, R. Pitstick, G.A. Carlson, B.J. Bacskai, and T.L. Spires-Jones Caspase activation precedes and leads to tangles Nature 464 2010 1201 1204
148. B. Tizon, E.M. Ribe, W. Mi, C.M. Troy, and E. Levy Cystatin C protects neuronal cells from amyloid-beta-induced toxicity J Alzheimers Dis 19 2010 885 894
149. M.T. Heneka, and M.K. O'Banion Inflammatory processes in Alzheimer's disease J Neuroimmunol 184 2007 69 91
150. J. Ojala, I. Alafuzoff, S.K. Herukka, T. van Groen, H. Tanila, and T. Pirttila Expression of interleukin-18 is increased in the brains of Alzheimer's disease patients Neurobiol Aging 30 2009 198 209
151. G. Zuliani, M. Ranzini, G. Guerra, L. Rossi, M.R. Munari, and A. Zurlo Plasma cytokines profile in older subjects with late onset Alzheimer's disease or vascular dementia J Psychiatr Res 41 2007 686 693
152. L.F. Lue, R. Rydel, E.F. Brigham, L.B. Yang, H. Hampel, and G.M. Murphy Jr. Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro Glia 35 2001 72 79
153. J. Apelt, and R. Schliebs Beta-amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology Brain Res 894 2001 21 30
154. A. Halle, V. Hornung, G.C. Petzold, C.R. Stewart, B.G. Monks, and T. Reinheckel The NALP3 inflammasome is involved in the innate immune response to amyloid-beta Nat Immunol 9 2008 857 865
155. J.A. Kummer, R. Broekhuizen, H. Everett, L. Agostini, L. Kuijk, and F. Martinon Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response J Histochem Cytochem 55 2007 443 452
156. V. Petrilli, S. Papin, C. Dostert, A. Mayor, F. Martinon, and J. Tschopp Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration Cell Death Differ 14 2007 1583 1589
157. J.P. de Rivero Vaccari, G. Lotocki, A.E. Marcillo, W.D. Dietrich, and R.W. Keane A molecular platform in neurons regulates inflammation after spinal cord injury J Neurosci 28 2008 3404 3414
158. C. Frederick Lo, X. Ning, C. Gonzales, and B.A. Ozenberger Induced expression of death domain genes NALP1 and NALP5 following neuronal injury Biochem Biophys Res Commun 366 2008 664 669
159. L.V. Colom, M.E. Diaz, D.R. Beers, A. Neely, W.J. Xie, and S.H. Appel Role of potassium channels in amyloid-induced cell death J Neurochem 70 1998 1925 1934
160. S.P. Yu, Z.S. Farhangrazi, H.S. Ying, C.H. Yeh, and D.W. Choi Enhancement of outward potassium current may participate in beta-amyloid peptide-induced cortical neuronal death Neurobiol Dis 5 1998 81 88
161. C.M. Troy, S.A. Rabacchi, W.J. Friedman, T.F. Frappier, K. Brown, and M.L. Shelanski Caspase-2 mediates neuronal cell death induced by beta-amyloid J Neurosci 20 2000 1386 1392
162. T. Nakagawa, H. Zhu, N. Morishima, E. Li, J. Xu, and B.A. Yankner Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta Nature 403 2000 98 103
163. S. Song, H. Lee, T.I. Kam, M.L. Tai, J.Y. Lee, and J.Y. Noh E2-25K/Hip-2 regulates caspase-12 in ER stress-mediated Abeta neurotoxicity J Cell Biol 182 2008 675 684
164. M. Saleh, J.P. Vaillancourt, R.K. Graham, M. Huyck, S.M. Srinivasula, and E.S. Alnemri Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms Nature 429 2004 75 79
165. J. Hitomi, T. Katayama, Y. Eguchi, T. Kudo, M. Taniguchi, and Y. Koyama Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Abeta-induced cell death J Cell Biol 165 2004 347 356
166. T. Vaisid, S. Barnoy, and N.S. Kosower Calpain activates caspase-8 in neuron-like differentiated PC12 cells via the amyloid-beta-peptide and CD95 pathways Int J Biochem Cell Biol 41 2009 2450 2458
167. T. Vaisid, N.S. Kosower, E. Elkind, and S. Barnoy Amyloid beta peptide toxicity in differentiated PC12 cells: calpain-calpastatin, caspase, and membrane damage J Neurosci Res 86 2008 2314 2325
168. D.C. Lu, G.M. Shaked, E. Masliah, D.E. Bredesen, and E.H. Koo Amyloid beta protein toxicity mediated by the formation of amyloid-beta protein precursor complexes Ann Neurol 54 2003 781 789
169. K.F. Lin, R.C. Chang, K.C. Suen, K.F. So, and J. Hugon Modulation of calcium/calmodulin kinase-II provides partial neuroprotection against beta-amyloid peptide toxicity Eur J Neurosci 19 2004 2047 2055
170. S.D. Ryan, S.N. Whitehead, L.A. Swayne, T.C. Moffat, W. Hou, and M. Ethier Amyloid-{beta}42 signals tau hyperphosphorylation and compromises neuronal viability by disrupting alkylacylglycerophosphocholine metabolism Proc Natl Acad Sci USA 97 2008 60 78
171. G. Tesco, Y.H. Koh, E.L. Kang, A.N. Cameron, S. Das, and M. Sena-Esteves Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity Neuron 54 2007 721 737
172. C.P. Warlow Epidemiology of stroke Lancet 352 Suppl. 3 1998 1 4
173. G.J. del Zoppo Stroke and neurovascular protection N Engl J Med 354 2006 553 555
174. E.M. Ribe, E. Serrano-Saiz, N. Akpan, and C.M. Troy Mechanisms of neuronal death in disease: defining the models and the players Biochem J 415 2008 165 182
175. J.H. Garcia, K.F. Liu, and K.L. Ho Neuronal necrosis after middle cerebral artery occlusion in Wistar rats progresses at different time intervals in the caudoputamen and the cortex Stroke 26 1995 636 642 [Discussion: 643]
176. P. Lipton Ischemic cell death in brain neurons Physiol Rev 79 1999 1431 1568
177. M.D. Linnik, R.H. Zobrist, and M.D. Hatfield Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats Stroke 24 1993 2002 2008 [Discussion: 20082009]
178. C. Charriaut-Marlangue, I. Margaill, A. Represa, T. Popovici, M. Plotkine, and Y. Ben-Ari Apoptosis and necrosis after reversible focal ischemia: an in situ DNA fragmentation analysis J Cereb Blood Flow Metab 16 1996 186 194
179. P. Li, H. Allen, S. Banerjee, S. Franklin, L. Herzog, and C. Johnston Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock Cell 80 1995 401 411
180. A. Benchoua, C. Guegan, C. Couriaud, H. Hosseini, N. Sampaio, and D. Morin Specific caspase pathways are activated in the two stages of cerebral infarction J Neurosci 21 2001 7127 7134
181. J.F. Kerr, A.H. Wyllie, and A.R. Currie Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics Br J Cancer 26 1972 239 257
182. M.P. Mattson Apoptosis in neurodegenerative disorders Nat Rev Mol Cell Biol 1 2000 120 129
183. S. Love Apoptosis and brain ischaemia Prog Neuropsychopharmacol Biol Psychiatry 27 2003 267 282
184. I. Ferrer Apoptosis: future targets for neuroprotective strategies Cerebrovasc Dis 21 Suppl 2 2006 9 20
185. L.J. Martin, N.A. Al-Abdulla, A.M. Brambrink, J.R. Kirsch, F.E. Sieber, and C. Portera-Cailliau Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: a perspective on the contributions of apoptosis and necrosis Brain Res Bull 46 1998 281 309
186. J. Pan, A.A. Konstas, B. Bateman, G.A. Ortolano, and J. Pile-Spellman Reperfusion injury following cerebral ischemia: pathophysiology, MR imaging, and potential therapies Neuroradiology 49 2007 93 102
187. T. Kahles, P. Luedike, M. Endres, H.J. Galla, H. Steinmetz, and R. Busse NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke Stroke 38 2007 3000 3006
188. R.J. Traystman Animal models of focal and global cerebral ischemia ILAR J 44 2003 85 95
189. A. Richard Green, T. Odergren, and T. Ashwood Animal models of stroke: do they have value for discovering neuroprotective agents? Trends Pharmacol Sci 24 2003 402 408
190. M.A. Dronne, E. Grenier, G. Chapuisat, M. Hommel, and J.P. Boissel A modelling approach to explore some hypotheses of the failure of neuroprotective trials in ischemic stroke patients Prog Biophys Mol Biol 97 2008 60 78
191. S.M. Rothman Synaptic activity mediates death of hypoxic neurons Science 220 1983 536 537
192. M.P. Goldberg, and D.W. Choi Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calcium-independent mechanisms of neuronal injury J Neurosci 13 1993 3510 3524
193. B.J. Gwag, D. Lobner, J.Y. Koh, M.B. Wie, and D.W. Choi Blockade of glutamate receptors unmasks neuronal apoptosis after oxygen-glucose deprivation in vitro Neuroscience 68 1995 615 619
194. J.H. Laake, F.M. Haug, T. Wieloch, and O.P. Ottersen A simple in vitro model of ischemia based on hippocampal slice cultures and propidium iodide fluorescence Brain Res Brain Res Protoc 4 1999 173 184
195. A. Schurr, R.S. Payne, J.J. Miller, and B.M. Rigor Study of cerebral energy metabolism using the rat hippocampal slice preparation Methods 18 1999 117 126
196. A. Schurr, M.T. Tseng, C.A. West, and B.M. Rigor Taurine improves the recovery of neuronal function following cerebral hypoxia: an in vitro study Life Sci 40 1987 2059 2066
197. P. Calabresi, D. Centonze, and G. Bernardi Cellular factors controlling neuronal vulnerability in the brain: a lesson from the striatum Neurology 55 2000 1249 1255
198. J.Z. Pedersen, G. Bernardi, D. Centonze, A. Pisani, L. Rossi, and G. Rotilio Hypoglycemia, hypoxia, and ischemia in a corticostriatal slice preparation: electrophysiologic changes and ascorbyl radical formation J Cereb Blood Flow Metab 18 1998 868 875
199. H. Benveniste, J. Drejer, A. Schousboe, and N.H. Diemer Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis J Neurochem 43 1984 1369 1374
200. D.W. Choi, and S.M. Rothman The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death Annu Rev Neurosci 13 1990 171 182
201. R.P. Simon, J.H. Swan, T. Griffiths, and B.S. Meldrum Blockade of N-methyl-d-aspartate receptors may protect against ischemic damage in the brain Science 226 1984 850 852
202. C. Malagelada, X. Xifro, A. Minano, J. Sabria, and J. Rodriguez-Alvarez Contribution of caspase-mediated apoptosis to the cell death caused by oxygenglucose deprivation in cortical cell cultures Neurobiol Dis 20 2005 27 37
203. E. Meli, M. Pangallo, R. Baronti, A. Chiarugi, A. Cozzi, and D.E. Pellegrini-Giampietro Poly(ADP-ribose) polymerase as a key player in excitotoxicity and post-ischemic brain damage Toxicol Lett 139 2003 153 162
204. F. Moroni, E. Meli, F. Peruginelli, A. Chiarugi, A. Cozzi, and R. Picca Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia Cell Death Differ 8 2001 921 932
205. A.M. Ray, D.E. Owen, M.L. Evans, J.B. Davis, and C.D. Benham Caspase inhibitors are functionally neuroprotective against oxygen glucose deprivation induced CA1 death in rat organotypic hippocampal slices Brain Res 867 2000 62 69
206. F.J. Gottron, H.S. Ying, and D.W. Choi Caspase inhibition selectively reduces the apoptotic component of oxygen-glucose deprivation-induced cortical neuronal cell death Mol Cell Neurosci 9 1997 159 169
207. A.G. Taranukhin, E.Y. Taranukhina, P. Saransaari, I.M. Djatchkova, M. Pelto-Huikko, and S.S. Oja Taurine reduces caspase-8 and caspase-9 expression induced by ischemia in the mouse hypothalamic nuclei Amino Acids 34 2008 169 174
208. D.A. Le, Y. Wu, Z. Huang, K. Matsushita, N. Plesnila, and J.C. Augustinack Caspase activation and neuroprotection in caspase-3-deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation Proc Natl Acad Sci USA 99 2002 15188 15193
209. Y.C. Shang, Z.Z. Chong, J. Hou, and K. Maiese FoxO3a governs early microglial proliferation and employs mitochondrial depolarization with caspase 3, 8, and 9 cleavage during oxidant induced apoptosis Curr Neurovasc Res 6 2009 223 238
210. C.M. Troy, D. Derossi, A. Prochiantz, L.A. Greene, and M.L. Shelanski Downregulation of Cu/Zn superoxide dismutase leads to cell death via the nitric oxide-peroxynitrite pathway J Neurosci 16 1996 253 261
211. T.J. Davidson, S. Harel, V.A. Arboleda, G.F. Prunell, M.L. Shelanski, and L.A. Greene Highly efficient small interfering RNA delivery to primary mammalian neurons induces MicroRNA-like effects before mRNA degradation J Neurosci 24 2004 10040 10046
212. M. Fujimura, Y. Morita-Fujimura, N. Noshita, T. Sugawara, M. Kawase, and P.H. Chan The cytosolic antioxidant copper/zinc-superoxide dismutase prevents the early release of mitochondrial cytochrome c in ischemic brain after transient focal cerebral ischemia in mice J Neurosci 20 2000 2817 2824
213. T. Kondo, A.G. Reaume, T.T. Huang, E. Carlson, K. Murakami, and S.F. Chen Reduction of CuZn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient focal cerebral ischemia J Neurosci 17 1997 4180 4189
214. H. Boutin, R.A. LeFeuvre, R. Horai, M. Asano, Y. Iwakura, and N.J. Rothwell Role of IL-1alpha and IL-1beta in ischemic brain damage J Neurosci 21 2001 5528 5534
215. N. Rothwell Interleukin-1 and neuronal injury: mechanisms, modification, and therapeutic potential Brain Behav Immun 17 2003 152 157
216. R.M. Friedlander, V. Gagliardini, H. Hara, K.B. Fink, W. Li, and G. MacDonald Expression of a dominant negative mutant of interleukin-1 beta converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury J Exp Med 185 1997 933 940
217. G.P. Schielke, G.Y. Yang, B.D. Shivers, and A.L. Betz Reduced ischemic brain injury in interleukin-1 beta converting enzyme-deficient mice J Cereb Blood Flow Metab 18 1998 180 185
218. S.M. Allan, P.J. Tyrrell, and N.J. Rothwell Interleukin-1 and neuronal injury Nat Rev Immunol 5 2005 629 640
219. I. Ferrer, and A.M. Planas Signaling of cell death and cell survival following focal cerebral ischemia: life and death struggle in the penumbra J Neuropathol Exp Neurol 62 2003 329 339
220. K. Niizuma, H. Endo, C. Nito, D.J. Myer, G.S. Kim, and P.H. Chan The PIDDosome mediates delayed death of hippocampal CA1 neurons after transient global cerebral ischemia in rats Proc Natl Acad Sci USA 105 2008 16368 16373
221. J.J. Velier, J.A. Ellison, K.K. Kikly, P.A. Spera, F.C. Barone, and G.Z. Feuerstein Caspase-8 and caspase-3 are expressed by different populations of cortical neurons undergoing delayed cell death after focal stroke in the rat J Neurosci 19 1999 5932 5941
222. C. Guegan, and B. Sola Early and sequential recruitment of apoptotic effectors after focal permanent ischemia in mice Brain Res 856 2000 93 100
223. S. Love, R. Barber, A. Srinivasan, and G.K. Wilcock Activation of caspase-3 in permanent and transient brain ischaemia in man NeuroReport 11 2000 2495 2499
224. R.G. Giffard, and R.A. Swanson Ischemia-induced programmed cell death in astrocytes Glia 50 2005 299 306
225. S.R. Duan, J.X. Wang, J. Wang, R. Xu, J.K. Zhao, and D.S. Wang Ischemia induces endoplasmic reticulum stress and cell apoptosis in human brain Neurosci Lett 475 2010 132 135
226. D.C. Harrison, R.P. Davis, B.C. Bond, C.A. Campbell, M.F. James, and A.A. Parsons Caspase mRNA expression in a rat model of focal cerebral ischemia Brain Res Mol Brain Res 89 2001 133 146
227. D.W. Desmond, J.T. Moroney, M. Sano, and Y. Stern Incidence of dementia after ischemic stroke: results of a longitudinal study Stroke 33 2002 2254 2260
228. T.K. Tatemichi, D.W. Desmond, Y. Stern, M. Paik, M. Sano, and E. Bagiella Cognitive impairment after stroke: frequency, patterns, and relationship to functional abilities J Neurol Neurosurg Psychiatry 57 1994 202 207
229. T.K. Tatemichi, M. Paik, E. Bagiella, D.W. Desmond, Y. Stern, and M. Sano Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study Neurology 44 1994 1885 1891
230. Y. Wen, S. Yang, R. Liu, A.M. Brun-Zinkernagel, P. Koulen, and J.W. Simpkins Transient cerebral ischemia induces aberrant neuronal cell cycle re-entry and Alzheimer's disease-like tauopathy in female rats J Biol Chem 279 2004 22684 22692
231. T. Nihashi, S. Inao, Y. Kajita, T. Kawai, T. Sugimoto, and M. Niwa Expression and distribution of beta amyloid precursor protein and beta amyloid peptide in reactive astrocytes after transient middle cerebral artery occlusion Acta Neurochir (Wien) 143 2001 287 295
232. T. van Groen, K. Puurunen, H.M. Maki, J. Sivenius, and J. Jolkkonen Transformation of diffuse beta-amyloid precursor protein and beta-amyloid deposits to plaques in the thalamus after transient occlusion of the middle cerebral artery in rats Stroke 36 2005 1551 1556
233. M. Xiong, T. Zhang, L.M. Zhang, S.D. Lu, Y.L. Huang, and F.Y. Sun Caspase inhibition attenuates accumulation of beta-amyloid by reducing beta-secretase production and activity in rat brains after stroke Neurobiol Dis 32 2008 433 441
234. E.E. Abrahamson, M.D. Ikonomovic, J.R. Ciallella, C.E. Hope, W.R. Paljug, and B.A. Isanski Caspase inhibition therapy abolishes brain trauma-induced increases in Abeta peptide: implications for clinical outcome Exp Neurol 197 2006 437 450
235. S.S. Chae, C.B. Yoo, C. Jo, S.M. Yun, S.A. Jo, and Y.H. Koh Caspases-2 and -8 are involved in the presenilin1/gamma-secretase-dependent cleavage of amyloid precursor protein after the induction of apoptosis J Neurosci Res 88 2010 1926 1933
236. A. de Calignon, L.M. Fox, R. Pitstick, G.A. Carlson, B.J. Bacskai, and T.L. Spires-Jones Caspase activation precedes and leads to tangles Nature 464 2010 1201 1204
237. J.H. Su, M. Zhao, A.J. Anderson, A. Srinivasan, and C.W. Cotman Activated caspase-3 expression in Alzheimer's and aged control brain: correlation with Alzheimer pathology Brain Res 898 2001 350 357
238. N. Louneva, J.W. Cohen, L.Y. Han, K. Talbot, R.S. Wilson, and D.A. Bennett Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer's disease Am J Pathol 173 2008 1488 1495
239. 2+ homeostasis under the ER stress Neurochem Int 56 2010 352 356
240. T.T. Rohn, R.A. Rissman, M.C. Davis, Y.E. Kim, C.W. Cotman, and E. Head Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain Neurobiol Dis 11 2002 341 354
241. K. Ishige, N. Takagi, T. Imai, W.D. Rausch, Y. Kosuge, and T. Kihara Role of caspase-12 in amyloid beta-peptide-induced toxicity in organotypic hippocampal slices cultured for long periods J Pharmacol Sci 104 2007 46 55
242. R.M. Friedlander, R.H. Brown, V. Gagliardini, J. Wang, and J. Yuan Inhibition of ICE slows ALS in mice [letter] [published erratum appears in Nature 1998 Apr 9;392(6676):560] Nature 388 1997 31
243. M. Krajewska, R.E. Rosenthal, J. Mikolajczyk, H.R. Stennicke, T. Wiesenthal, and J. Mai Early processing of Bid and caspase-6, -8, -10, -14 in the canine brain during cardiac arrest and resuscitation Exp Neurol 189 2004 261 279